Related Experiment Video
Updated: Dec 13, 2025
Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
Remodeling of the ARID1A tumor suppressor
Qingyu Luo1, Xiaowei Wu1, Zhihua Liu1
1State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Abstract:
In recent years, AT-rich interactive domain-containing protein 1A (ARID1A) has been widely accepted as a bona fide tumor suppressor due to its essential role in preventing tumorigenesis and tumor progression in both mouse and human contexts. ARID1A shows high mutation frequencies in both cancers and preneoplastic lesions. The loss of ARID1A expression in cancer cells leads to increases in cell proliferation, invasion and migration and reductions in cell apoptosis and chemosensitivity. The tumor-suppressive role of ARID1A is mainly attributed to its regulation of gene transcription, which can be induced either directly by chromatin remodeling or indirectly by affecting histone modifications. ARID1A also acts independently of its cardinal transcription-regulating mechanisms, which include interfering with protein-protein interactions. Interestingly, nonmutational mechanisms, such as regulation by DNA hypermethylation, microRNAs, and ubiquitinases/deubiquitinases, have provided another perspective on ARID1A inactivation in cancer. Since the critical tumor-suppressive role of ARID1A has been revealed, several studies have attempted to identify synthetic lethal targets with ARID1A mutation/inactivation as an alternative strategy for cancer treatment.
Insights
AT-rich interactive domain-containing protein 1A (ARID1A) is a tumor suppressor crucial for preventing cancer. Its inactivation, through mutations or other mechanisms, promotes tumor growth and reduces treatment sensitivity, highlighting potential therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- AT-rich interactive domain-containing protein 1A (ARID1A) is recognized as a tumor suppressor involved in preventing tumorigenesis and tumor progression.
- ARID1A mutations are frequent in various cancers and preneoplastic lesions, impacting cellular functions.
- Loss of ARID1A expression correlates with increased proliferation, invasion, migration, and decreased apoptosis and chemosensitivity in cancer cells.
Purpose of the Study:
- To review the multifaceted roles of ARID1A in cancer, including its tumor-suppressive functions and mechanisms of inactivation.
- To explore the non-canonical functions of ARID1A beyond transcription regulation.
- To highlight the therapeutic potential of targeting synthetic lethal interactions in ARID1A-mutated cancers.
Main Methods:
- Review of existing literature on ARID1A function, mutation, and inactivation in cancer.
- Analysis of ARID1A's roles in gene transcription regulation via chromatin remodeling and histone modifications.
- Investigation of ARID1A's non-transcriptional activities, including protein-protein interactions.
Main Results:
- ARID1A's tumor-suppressive activity is mediated through direct chromatin remodeling and indirect effects on histone modifications.
- ARID1A also exerts tumor-suppressive effects independently of transcription regulation, by interfering with protein-protein interactions.
- Non-mutational inactivation mechanisms, including DNA hypermethylation and microRNA/ubiquitinase regulation, contribute to ARID1A loss in cancer.
Conclusions:
- ARID1A is a critical tumor suppressor whose inactivation promotes cancer development and progression.
- Understanding ARID1A's diverse mechanisms of action and inactivation is key to developing novel cancer therapies.
- Identifying synthetic lethal targets offers a promising therapeutic strategy for cancers with ARID1A mutations.
Related Concept Videos
02:23Abnormal Proliferation
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
03:03mTOR Signaling and Cancer Progression
The mTOR pathway or the...
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...